Glyscend Therapeutics has a total of 38 patents globally, out of which 13 have been granted. Of these 38 patents, more than 89% patents are active. The United States of America is where Glyscend Therapeutics has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Glyscend Therapeutics.
Glyscend Therapeutics was founded in 2014. This company creates special medications using a type of material that targets the stomach. These drugs are made to treat conditions like type 2 diabetes and other ongoing health issues. The main product is a pill that you swallow, but it doesn’t get absorbed into the body. Instead, it stays in the stomach and works like a treatment that mimics the effects of weight loss surgery.
Do read about some of the most popular patents of Glyscend Therapeutics which have been covered by us in this article and also you can find Glyscend Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Glyscend Therapeutics patent portfolio.
How many patents does Glyscend Therapeutics have?
Glyscend Therapeutics has a total of 38 patents globally. These patents belong to 6 unique patent families. Out of 38 patents, 34 patents are active.
How Many Patents did Glyscend Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Glyscend Therapeutics Applications Filed | Glyscend Therapeutics Patents Granted |
| 2023 | 2 | 1 |
| 2022 | 4 | 3 |
| 2021 | 4 | 1 |
| 2020 | 16 | 1 |
| 2019 | 5 | 2 |
| 2017 | 2 | 2 |
| 2015 | 1 | 1 |
| 2014 | 2 | 1 |
| 2012 | 1 | 1 |
How many Glyscend Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Glyscend Therapeutics File in Different Countries?
Countries in which Glyscend Therapeutics Filed Patents
| Country | Patent |
| United States Of America | 19 |
| Japan | 3 |
| Europe | 3 |
| Australia | 1 |
| Canada | 1 |
| India | 1 |
| Mexico | 1 |
| China | 1 |
| New Zealand | 1 |
| Brazil | 1 |
| Singapore | 1 |
| Hong Kong (S.A.R.) | 1 |
| Israel | 1 |
Where are Research Centers of Glyscend Therapeutics Patents Located?
The Research Centers of Glyscend Therapeutics Patents is the United States of America.
10 Best Glyscend Therapeutics Patents
US8142775B2 is the most popular patent in the Glyscend Therapeutics portfolio. It has received 10 citations so far from companies like Allena Pharmaceuticals, Ajinomoto Althea, Oxidien Pharmaceuticals.
Below is the list of 10 most cited patents of Glyscend Therapeutics:
| Publication Number | Citation Count |
| US8142775B2 | 10 |
| US8741284B2 | 8 |
| US9155785B2 | 7 |
| WO2020061430A1 | 7 |
| US9821041B2 | 4 |
| US9714456B2 | 4 |
| WO2021055759A1 | 4 |
| WO2021055752A1 | 4 |
| US10369203B2 | 3 |
| US10246755B2 | 2 |
What Percentage of Glyscend Therapeutics US Patent Applications Were Granted?
Glyscend Therapeutics (Excluding its subsidiaries) has filed 6 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 100%.
Below are the key stats of Glyscend Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Glyscend Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Hogan Lovells Us Llp | 6 | 100% |
List of Glyscend Therapeutics patents
| Glyscend Therapeutics Patents | Title |
| US11576928B2 | Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use |
| US11491182B2 | Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use |
| US11491183B2 | Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use |
| US11484548B2 | Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use |
| US11208700B2 | Crystallized Oxalate Decarboxylase And Methods Of Use |
| US10570468B2 | Crystallized Oxalate Decarboxylase And Methods Of Use |
| US10369203B2 | Crystallized Oxalate Decarboxylase And Methods Of Use |
| US10246755B2 | Crystallized Oxalate Decarboxylase And Methods Of Use |
| US9821041B2 | Crystallized Oxalate Decarboxylase And Methods Of Use |
| US9714456B2 | Crystallized Oxalate Decarboxylase And Methods Of Use |
| US9155785B2 | Crystallized Oxalate Decarboxylase And Methods Of Use |
| US8741284B2 | Crystallized Oxalate Decarboxylase And Methods Of Use |
| US8142775B2 | Crystallized Oxalate Decarboxylase And Methods Of Use |
| US20230338415A1 | Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use |
| US20220403361A1 | Crystallized Oxalate Decarboxylase And Methods Of Use |
| US20220396651A1 | Benzoxaborole Polymers And Methods Of Use |
| US20220378886A1 | Methods Of Treating Hyperoxaluria |
| US20210403625A1 | Boronic Acid Polymers And Methods Of Use |
| EP4031553A4 | Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use |
| EP4041740A4 | Benzoxaborole Polymers And Methods Of Use |
| EP3852768A4 | Boronic Acid Polymers And Methods Of Use |
| CN114423768A | Substituted Phenylboronic Acid-Containing Polymers And Methods Of Use |
| JP2022548699A5 | Substituted Phenylboronic Acid-Containing Polymers And Methods Of Use |
| JP2022548698A5 | Benzoxaborol Polymers And Methods Of Use |
| JP2022501483A5 | Boronic Acid Polymers And Methods Of Use |
| HK40078118A | Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use |
| IN202217020746A | Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use |
| MX2022003384A | Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use. |
| BR112022004981A2 | Substituted Phenylboronic Acid Containing Polymers And Methods Of Use |
| IL291462A | Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use |
| SG11202202168VA | Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use |
| AU2020348451A1 | Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use |
| NZ786964A | Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use |
| CA3150057A1 | Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use |
| US20220133865A1 | Crystallized Oxalate Decarboxylase And Methods Of Use |
| WO2021055759A1 | Substituted Phenyl Boronic Acid Containing Polymers And Methods Of Use |
| WO2021055752A1 | Benzoxaborole Polymers And Methods Of Use |
| WO2020061430A1 | Boronic Acid Polymers And Methods Of Use |
What are Glyscend Therapeutics key innovation segments?
What Technologies are Covered by Glyscend Therapeutics?
The chart below distributes patents filed by Glyscend Therapeutics